Sinovac: Sahpra approval a ‘turning point’ for SA’s vaccine rollout
The Sinovac vaccine is indicated for active immunisation in individuals aged between 18 and 59 years against Covid-19.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
